What is Pulmonx Corporation's AOCI?

Pulmonx Corporation (LUNG) reported AOCI of $2.17M in Q1 2026.

How has Pulmonx Corporation's AOCI changed year-over-year?

Pulmonx Corporation's AOCI decreased by 1.5% year-over-year, from $2.2M to $2.17M.

What is the long-term trend for Pulmonx Corporation's AOCI?

Over 5 years (2020 to 2025), Pulmonx Corporation's AOCI has grown at a 7.0% compound annual growth rate (CAGR), from $1.69M to $2.36M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Pulmonx Corporation LUNG AOCI

AOCI at other companies

Intuitive SurgicalISRG

$16.5M+161%

Theravance BiopharmaTBPH

-$62K—

SavaraSVRA

-$429K+32.1%

United TherapeuticsUTHR

-$10.2M-750%

Zevra Therapeutics, Inc.ZVRA

-$1.8M-2,091%

LivaNovaLIVN

-$3.4M+92.0%

Other financials

Income statement

See full

Revenue$20.6M-8.7%

Gross profit$16.0M-1.8%

Operating income-$13.0M+11.0%

Net income-$13.7M+5.5%

EPS (diluted)-$0.33+8.3%

Balance sheet

See full

Cash & equivalents$61.0M-2.4%

Total debt$56.3M-1.2%

Total equity$45.8M-41.1%

Total assets$120.0M-20.4%

Cash flow

See full

Operating cash flow-$10.1M+23.6%

CapEx$9.0K-97.0%

Free cash flow-$10.1M+25.3%

Valuation

See full

Market cap$54.91M-47.3%

Enterprise value$50.17M-43.5%

P/S0.6×-0.5×

Profitability

See full

Gross margin75.5%+2.0pp

Operating margin-58.8%-5.8pp

Net margin-60.1%-4.4pp

FCF margin-33.2%-4.4pp

Returns & leverage

See full

Return on equity-86.2%+62.6pp

Debt / equity1.2×+0.5×

Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulmonx Corporation's AOCI?: Pulmonx Corporation (LUNG) reported AOCI of $2.17M in Q1 2026.
How has Pulmonx Corporation's AOCI changed year-over-year?: Pulmonx Corporation's AOCI decreased by 1.5% year-over-year, from $2.2M to $2.17M.
What is the long-term trend for Pulmonx Corporation's AOCI?: Over 5 years (2020 to 2025), Pulmonx Corporation's AOCI has grown at a 7.0% compound annual growth rate (CAGR), from $1.69M to $2.36M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.